Olfactory immune response to SARS-CoV-2

SA Wellford, EA Moseman - Cellular & Molecular Immunology, 2024 - nature.com
Numerous pathogens can infect the olfactory tract, yet the pandemic caused by SARS-CoV-
2 has strongly emphasized the importance of the olfactory mucosa as an immune barrier …

Same yet different—how lymph node heterogeneity affects immune responses

P Cruz de Casas, K Knöpper, R Dey Sarkar… - Nature Reviews …, 2024 - nature.com
Lymph nodes are secondary lymphoid organs in which immune responses of the adaptive
immune system are initiated and regulated. Distributed throughout the body and embedded …

An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission

JM Adler, R Martin Vidal, C Langner… - Nature …, 2024 - nature.com
The development of effective SARS-CoV-2 vaccines has been essential to control COVID-
19, but significant challenges remain. One problem is intramuscular administration, which …

Nasal delivery as a strategy for the prevention and treatment of COVID-19

F Sonvico, G Colombo, E Quarta… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The upper respiratory tract is a major route of infection for COVID-19 and other
respiratory diseases. Thus, it appears logical to exploit the nose as administration site to …

Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses

W Fu, M Guo, X Zhou, Z Wang, J Sun, Y An, T Guan… - ACS …, 2024 - ACS Publications
Intranasal vaccines, eliciting mucosal immune responses, can prevent early invasion,
replication, and transmission of pathogens in the respiratory tract. However, the effective …

Challenges and prospects in developing future SARS-CoV-2 vaccines: Overcoming original antigenic sin and inducing broadly neutralizing antibodies

JP Evans, SL Liu - The Journal of Immunology, 2023 - journals.aai.org
The impacts of the COVID-19 pandemic led to the development of several effective SARS-
CoV-2 vaccines. However, waning vaccine efficacy as well as the antigenic drift of SARS …

A non-transmissible live attenuated SARS-CoV-2 vaccine

JM Adler, RM Vidal, A Voß, S Kunder, M Nascimento… - Molecular Therapy, 2023 - cell.com
Live attenuated vaccines (LAVs) administered via the mucosal route may offer better control
of the COVID-19 pandemic than non-replicating vaccines injected intramuscularly …

Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines

K Chen, L Zhang, Z Fang, J Li, C Li, W Song… - Frontiers in …, 2023 - frontiersin.org
By the end of 2022, different variants of Omicron had rapidly spread worldwide, causing a
significant impact on the Coronavirus disease 2019 (COVID-19) pandemic situation …

Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness

A Chattopadhyay, AAK Jailani, B Mandal - Vaccines, 2023 - mdpi.com
After two years since the declaration of COVID-19 as a pandemic by the World Health
Organization (WHO), more than six million deaths have occurred due to SARS-CoV-2 …

[HTML][HTML] Reverse genetics systems for SARS-CoV-2: Development and applications

HL Cai, YW Huang - Virologica Sinica, 2023 - Elsevier
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
caused serious harm to human health and struck a blow to global economic development …